<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14555">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02917408</url>
  </required_header>
  <id_info>
    <org_study_id>PBC-1</org_study_id>
    <nct_id>NCT02917408</nct_id>
  </id_info>
  <brief_title>Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital</brief_title>
  <official_title>Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiaoli Fan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study of all patients diagnosed with primary biliary cholangitis during
      January 2001 to July 2016 at West China Hospital by review of medical records. The following
      variables will be retrospectively studied: age, sex, first symptoms, clinical
      characteristics, pathology, treatment, stage, complications of cirrhosis, other autoimmune
      diseases and long-term outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of demographics, management patterns (clinical and diagnostic), comorbidities of PBC patients at diagnosis during the past 16 years.</measure>
    <time_frame>Up to 16 years.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of adverse outcome free survival of the PBC cohort during the 16 years.</measure>
    <time_frame>Up to 16 years.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cholangitis</condition>
  <condition>Liver Cirrhosis, Biliary</condition>
  <condition>Cholestasis</condition>
  <condition>Liver Diseases</condition>
  <condition>Liver Cirrhosis</condition>
  <condition>Bile Duct Diseases</condition>
  <arm_group>
    <arm_group_label>Primary biliary cholangitis during January 2001 to July 2016</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients diagnosed with primary biliary cholangitis during January 2001 to July 2016
        at West China Hospital by review of medical records.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newly diagnosis of PBC at West China Hospital during January 2001 to July 2016.

        Exclusion Criteria:

          -  Simultaneously diagnosed of autoimmune hepatitis or primary sclerosing cholangitis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li Yang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>West China Hospital,Chengdu, Sichuan, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaoli Fan, MM</last_name>
    <phone>+862885422311</phone>
    <email>13980433451@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>West China Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoli Fan, MM</last_name>
      <phone>+8618008028017</phone>
      <email>13980433451@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 23, 2017</lastchanged_date>
  <firstreceived_date>September 6, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital, Sichuan University</investigator_affiliation>
    <investigator_full_name>Xiaoli Fan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Bile Duct Diseases</mesh_term>
    <mesh_term>Liver Cirrhosis, Biliary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
